Results from a randomized, phase 2 clinical trial show that adding high-dose, intravenous (IV) vitamin C to chemotherapy ...

The rise in pancreatic cancer diagnoses can be attributed to detection of smaller, early-stage endocrine cancer, and not an increase in pancreatic adenocarcinoma, according to a study published Nov.

In the study, 34 patients with stage 4 metastatic pancreatic cancer were randomized ... the UI team also included cancer ...

OCALA, Fla., Nov. 19, 2024 (GLOBE NEWSWIRE) -- (NYSE American: AIM) (“AIM” or the “Company”) today announced that data were published on Roswell Park Comprehensive Cancer Center’s Phase 1 study ...

(“Panavance” or the “Company”), a clinical-stage pharmaceutical company advancing the development of a novel oncology therapeutic intended to improve the outcomes and quality of life for patients, ...

Protects the use of onvansertib in combination with standard of care in the KRAS mutated mCRC setting through 2043 - SAN DIEGO, Nov. 19, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: CRDF), a clinical-stage ...

Malignant ascites is a rare condition, most common in ovarian, pancreatic and gastric ... such as bladder cancer.” Prof. Carsten Bokemeyer, Director of the Department of Medical Oncology and ...

Catumaxomab received a positive opinion from the EMA's Committee for Medicinal Products for Human Use (CHMP) at its October 2024 meeting and if approved catumaxomab will be the only approved drug for ...

"Pharmanovia's supportive care focus, broad European platform and strong expertise in the oncology ... ovarian, pancreatic and gastric cancers with an incidence of 20 to 50 % of all cases. Malignant ...

Transaction valued at €3.5 millionThe partners have enjoyed a successful discovery collaboration since 2021LUND, SWEDEN / ACCESSWIRE / November 19, 2024 / Alligator Bioscience (STO:ATORX) today announ ...

Alligator is a clinical-stage biotechnology company developing tumor-directed immuno-oncology antibody drugs focused on ... data at 18-months follow up in first-line metastatic pancreatic cancer ...